comparemela.com
  1. Home
  2. Live Updates
  3. Isabelle Jaussent - Breaking News

Latest Breaking News On - Isabelle jaussent - Page 1 : comparemela.com

COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa

Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which there is currently no approved pharmacological

United kingdomCity ofAnna keski rahkonenIsabelle jaussentPaul liknaitzkyHans wijbrand hoekClairej foldiPhilippe courtetMartin williamsStephanie knatz peckStephen schultzAmy lawrenceSheppard prattJon arcelusWalterh kayeJackie wales

COMPASS Pathways launches phase II clinical trial of

Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which.

United kingdomUnited statesCity ofAnna keski rahkonenIsabelle jaussentPaul liknaitzkyHans wijbrand hoekClairej foldiPhilippe courtetMartin williamsStephanie knatz peckStephen schultzAmy lawrenceSheppard prattJon arcelusWalterh kaye

Investegate |COMPASS Pathways Announcements | COMPASS Pathways: COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa

Investegate announcements from COMPASS Pathways, COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa

United kingdomUnited statesCity ofAnna keski rahkonenIsabelle jaussentPaul liknaitzkyHans wijbrand hoekClairej foldiPhilippe courtetMartin williamsStephanie knatz peckStephen schultzAmy lawrenceSheppard prattJon arcelusWalterh kaye

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.